跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10 条关于
“Crenessity”
全部
10
临床试验
0
药物
0
机构
0
资讯
10
去年
CRENESSITY Shows Consistent Efficacy Across Pediatric CAH Subgroups While Reducing Glucocorticoid Doses
4个月前
Two-Year CRENESSITY Data Shows Sustained Benefits in Pediatric and Adult CAH Patients
去年
FDA Approves Multiple Breakthrough Therapies: Crenessity for CAH, Unloxcyt for Skin Cancer
去年
Neurocrine Biosciences' Crenessity Receives FDA Approval for Congenital Adrenal Hyperplasia
去年
FDA Approves Neurocrine's Crenessity (crinecerfont) for Congenital Adrenal Hyperplasia
去年
Neurocrine Biosciences Advances CAH Treatment Portfolio with Long-Acting Injectable Therapy
去年
Crinetics Pharmaceuticals Upgraded to "Buy" by Jefferies on Atumelnant Potential in CAH
去年
Crinecerfont Shows Promise in Pediatric Congenital Adrenal Hyperplasia Across All Patient Subgroups
9个月前
Neurocrine Biosciences Initiates Phase 2a Trial for Schizophrenia Treatment Following Depression Drug Setback
5个月前
Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Adding First-in-Class PWS Treatment